A study to investigate the effects of AZD0901 monotherapy in adult participants with 2L+ advanced or metastatic gastric or GEJ adenocarcinoma expressing CLDN18.2

Trial Identifier:	AZ-RU-00007
Sponsor:	AstraZeneca
Start Date:	August 2025
Primary Completion Date:	September 2026
Study Completion Date:	September 2027
Condition:	Gastric Cancer; Esophageal cancer

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service